Literature DB >> 33347924

Lack of Systemic Absorption of Topical Mechlorethamine Gel in Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.

Christiane Querfeld1, Larisa J Geskin2, Ellen J Kim3, Julia J Scarisbrick4, Pietro Quaglino5, Evangelia Papadavid6, James T Angello7, Pablo L Ortiz-Romero8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33347924      PMCID： PMC8641791          DOI： 10.1016/j.jid.2020.12.009

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   7.590


× No keyword cloud information.
  9 in total

1.  Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.

Authors:  L M Lindahl; M Fenger-Grøn; L Iversen
Journal:  Br J Dermatol       Date:  2014-03       Impact factor: 9.302

2.  Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma.

Authors:  E C Vonderheid; E T Tan; A F Kantor; L Shrager; B Micaily; E J Van Scott
Journal:  J Am Acad Dermatol       Date:  1989-03       Impact factor: 11.527

3.  Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  R Willemze; E Hodak; P L Zinzani; L Specht; M Ladetto
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

4.  Skin-Directed Therapies in Cutaneous T-Cell Lymphoma.

Authors:  Cuong V Nguyen; Kimberly A Bohjanen
Journal:  Dermatol Clin       Date:  2015-08-10       Impact factor: 3.478

Review 5.  European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Authors:  Franz Trautinger; Johanna Eder; Chalid Assaf; Martine Bagot; Antonio Cozzio; Reinhard Dummer; Robert Gniadecki; Claus-Detlev Klemke; Pablo L Ortiz-Romero; Evangelia Papadavid; Nicola Pimpinelli; Pietro Quaglino; Annamari Ranki; Julia Scarisbrick; Rudolf Stadler; Liisa Väkevä; Maarten H Vermeer; Sean Whittaker; Rein Willemze; Robert Knobler
Journal:  Eur J Cancer       Date:  2017-03-31       Impact factor: 9.162

Review 6.  The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Authors:  Rein Willemze; Lorenzo Cerroni; Werner Kempf; Emilio Berti; Fabio Facchetti; Steven H Swerdlow; Elaine S Jaffe
Journal:  Blood       Date:  2019-01-11       Impact factor: 22.113

Review 7.  Update on skin directed therapies in mycosis fungoides.

Authors:  Marie-Louise Lovgren; Julia J Scarisbrick
Journal:  Chin Clin Oncol       Date:  2018-11-28

8.  Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.

Authors:  Youn H Kim; Gina Martinez; Anna Varghese; Richard T Hoppe
Journal:  Arch Dermatol       Date:  2003-02

9.  Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.

Authors:  Stuart R Lessin; Madeleine Duvic; Joan Guitart; Amit G Pandya; Bruce E Strober; Elise A Olsen; Christopher M Hull; Elizabeth H Knobler; Alain H Rook; Ellen J Kim; Mark F Naylor; David M Adelson; Alexa B Kimball; Gary S Wood; Uma Sundram; Hong Wu; Youn H Kim
Journal:  JAMA Dermatol       Date:  2013-01       Impact factor: 10.282
  9 in total
  6 in total

1.  Chlormethine Gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma: In Vitro Release and Permeation Testing.

Authors:  Claudio Giuliano; Stefano Frizzarin; Alessandro Alonzi; Virginia Stimamiglio; Pablo L Ortiz-Romero
Journal:  Dermatol Ther (Heidelb)       Date:  2022-10-14

2.  The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.

Authors:  Ellen J Kim; Joan Guitart; Christiane Querfeld; Michael Girardi; Amy Musiek; Oleg E Akilov; James T Angello; William L Bailey; Larisa J Geskin
Journal:  Am J Clin Dermatol       Date:  2021-03-03       Impact factor: 7.403

3.  Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports.

Authors:  Kyriaki Lampadaki; Marios Koumourtzis; Fani Karagianni; Leonidas Marinos; Evangelia Papadavid
Journal:  Adv Ther       Date:  2021-04-30       Impact factor: 3.845

4.  Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions.

Authors:  Yun-Tsan Chang; Desislava Ignatova; Wolfram Hoetzenecker; Steve Pascolo; Christina Fassnacht; Emmanuella Guenova
Journal:  JID Innov       Date:  2021-11-25

Review 5.  Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings.

Authors:  Ulrike Wehkamp; Marco Ardigò; Evangelia Papadavid; Christiane Querfeld; Neda Nikbakht
Journal:  Adv Ther       Date:  2022-07-19       Impact factor: 4.070

6.  Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data.

Authors:  Christiane Querfeld; Julia J Scarisbrick; Chalid Assaf; Youn H Kim; Joan Guitart; Pietro Quaglino; Emmilia Hodak
Journal:  Am J Clin Dermatol       Date:  2022-05-10       Impact factor: 6.233
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.